We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
West Pharmaceutical
WST
$25.1B
| $13.7M | 0.02% |
124,242
+13,137
| +12% | +$1.37M |
|
627
Diamondback Energy
FANG
$58.9B
| $13.6M | 0.02% |
133,932
-10,466
| -7% | -$1.07M |
|
|
BKI
628
DELISTED
Black Knight, Inc. Common Stock
BKI
| $13.6M | 0.02% |
249,158
-4,207
| -2% | -$212K |
|
629
Broadridge
BR
$16.7B
| $13.6M | 0.02% |
130,759
-124,936
| -49% | -$12.5M |
|
630
Dycom Industries
DY
$13.3B
| $13.5M | 0.02% |
294,506
+8,195
| +3% | +$449K |
|
631
Atkore
ATKR
$2.49B
| $13.2M | 0.02% |
614,776
+248,419
| +68% | +$5.55M |
|
632
CubeSmart
CUBE
$9.37B
| $13.2M | 0.02% |
412,793
-5,279
| -1% | -$161K |
|
633
State Street
STT
$50.7B
| $13.2M | 0.02% |
200,407
-9,480
| -5% | -$657K |
|
634
MarketAxess Holdings
MKTX
$4.07B
| $13.1M | 0.02% |
53,380
+52,152
| +4,247% | +$11.8M |
|
635
Viatris
VTRS
$19.7B
| $13.1M | 0.02% |
462,007
-927,036
| -67% | -$27M |
|
636
Rigel Pharmaceuticals
RIGL
$689M
| $12.8M | 0.02% |
500,000
| – | – |
|
|
RHT
637
DELISTED
Red Hat Inc
RHT
| $12.7M | 0.02% |
69,311
+49,758
| +254% | +$8.92M |
|
|
BEAT
638
DELISTED
BioTelemetry, Inc.
BEAT
| $12.6M | 0.02% |
+201,653
| New | +$13.9M |
|
639
Heron Therapeutics
HRTX
$86.3M
| $12.6M | 0.02% |
515,908
+56,646
| +12% | +$1.48M |
|
640
Automatic Data Processing
ADP
$96.7B
| $12.5M | 0.02% |
78,105
+67,038
| +606% | +$9.74M |
|
641
Cardinal Health
CAH
$52.3B
| $12.5M | 0.02% |
258,683
+17,942
| +7% | +$899K |
|
642
Highwoods Properties
HIW
$3.66B
| $12.4M | 0.02% |
264,609
+9,269
| +4% | +$414K |
|
643
Devon Energy
DVN
$53.2B
| $12.3M | 0.02% |
389,189
-117,630
| -23% | -$3.29M |
|
644
Cathay General Bancorp
CATY
$4.19B
| $12.2M | 0.02% |
360,246
+8,600
| +2% | +$316K |
|
645
TAL Education Group
TAL
$5.74B
| $12.1M | 0.02% |
336,400
-8,900
| -3% | -$289K |
|
646
Fluor
FLR
$7.22B
| $12M | 0.02% |
326,875
-274,795
| -46% | -$10M |
|
|
PINC
647
DELISTED
Premier
PINC
| $11.9M | 0.01% |
345,523
-27,030
| -7% | -$999K |
|
648
PNC Financial Services
PNC
$98.5B
| $11.9M | 0.01% |
97,136
-6,072
| -6% | -$752K |
|
649
Cheniere Energy
LNG
$57.3B
| $11.6M | 0.01% |
169,748
+149,970
| +758% | +$9.86M |
|
650
NCR Voyix
VYX
$1.03B
| $11.6M | 0.01% |
691,594
+55,459
| +9% | +$918K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.